Log in to save to my catalogue

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10914850

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

About this item

Full title

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Publisher

Cham: Springer International Publishing

Journal title

Aging clinical and experimental research, 2024-03, Vol.36 (1), p.55-55, Article 55

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Progranulin is an anti-inflammatory protein that plays an essential role in the synapse function and the maintenance of neurons in the central nervous system (CNS). It has been shown that the CSF level of progranulin increases in Alzheimer’s disease (AD) patients and is associated with the deposition of amyloid-beta (Aβ) and tau in th...

Alternative Titles

Full title

Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10914850

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10914850

Other Identifiers

ISSN

1720-8319,1594-0667

E-ISSN

1720-8319

DOI

10.1007/s40520-024-02715-9

How to access this item